Preventable skin cancer up in Canada, study says

Melanoma cases are rising in Canada even though most other cancer rates are falling, a leading anti-cancer organization warned Wednesday, blaming tanning beds and slipping sunscreen use outdoors.

The Canadian Cancer Society said an estimated 6,500 new cases of and another 76,100 cases of non-melanoma skin cancers are expected to be diagnosed in this country in 2014.

Melanoma is the deadliest form of skin cancer, with 1,050 Canadians expected to die from it this year, it added.

"Melanoma is one of the fastest rising of all cancers in Canada," the organization said.

But it is also "one of the most preventable types of cancer."

The Canadian Cancer Society's research examined cancer trending since 1986. It cited surveys that found Canadians are spending more time in the sun without adequate protection.

The Canadian Cancer Society also blasted the use of high-output UV it says emit radiation "many times more than natural sun at midday in summer."

The organization recommended not tanning indoors, and wearing hats, sunglasses, protective clothing and sunscreen outdoors. It also recommended seeking shade, and planning outdoor activities before 11:00 am or after 4:00 pm.

add to favorites email to friend print save as pdf

Related Stories

FDA wants cancer warnings for tanning beds

May 06, 2013

Indoor tanning beds would carry new warnings about the risk of cancer and be subject to additional regulations, under a proposal unveiled by the Food and Drug Administration.

Skin cancer rates five times higher than in 70s

Apr 23, 2014

(Medical Xpress)—The rates of people diagnosed with malignant melanoma, the most serious form of skin cancer, are now five times higher than 40 years ago, according to figures announced by Cancer Research ...

Recommended for you

Cancerous tumors may spread by pure chance

2 hours ago

The spreading of a cancerous tumor from one part of the body to another may occur through pure chance instead of key genetic mutations, a new study has shown.

Lanreotide improves survival with enteropancreatic tumors

19 hours ago

(HealthDay)—Lanreotide significantly improves survival among patients with metastatic enteropancreatic neuroendocrine tumors (grade 1 or 2), according to a study published in the July 17 issue of the New En ...

User comments